journal article·2020-10

Colorectal Tumor Microenvironment‐Activated Bio‐Decomposable and Metabolizable Cu2O@CaCO3 Nanocomposites for Synergistic Oncotherapy

Mengyu Chang, Zhiyao Hou, Dayong Jin, Jiajia Zhou, Man Wang, Meifang Wang, Mengmeng Shu, Binbin Ding, Chunxia Li, Jun Lin

Advanced Materials· Volume 32· Issue 43
Publisher page

Abstract

Abstract Rational design of tumor microenvironment (TME)‐activated nanocomposites provides an innovative strategy to construct responsive oncotherapy. In colorectal cancer (CRC), the specific physiological features are the overexpressed endogenous H2S and slightly acidic microenvironment. Here, a core–shell Cu2O@CaCO3 nanostructure for CRC “turn‐on” therapy is reported. With CaCO3 responsive to pH decomposition and Cu2O responsive to H2S sulfuration, Cu2O@CaCO3 can be triggered “on” into the therapeutic mode by the colorectal TME. When the CaCO3 shell decomposes and releases calcium in acidic colorectal TME, the loss of protection from the CaCO3 shell exposes the Cu2O core to be sulfuretted by H2S to form metabolizable Cu31S16 nanocrystals that gain remarkably strong near‐infrared absorption. After modifying hyaluronic acid, Cu2O@CaCO3 can achieve synergistic CRC‐targeted and TME‐triggered photothermal/photodynamic/chemodynamic/calcium‐overload‐mediated therapy. Moreover, it is found that the generation of hyperthermia and oxidative stress from Cu2O@CaCO3 nanocomposites can efficiently reprogram the macrophages from the M2 phenotype to the M1 phenotype and initiate a vaccine‐like immune effect after primary tumor removal, which further induces an immune‐favorable TME and intense immune responses for anti‐CD47 antibody to simultaneously inhibit CRC distant metastasis and recurrence by immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Rare Earth Resource Utilization Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 P. R. China

School of Applied Chemistry and Engineering University of Sciences and Technology of China Hefei 230026 P. R. China

Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation School of Basic Medical Sciences Guangzhou Medical University Guangdong 511436 P. R. China

Department of Abdominal Surgery Affiliated Cancer Hospital & Institute of Guangzhou Medical University Guangzhou 510095 P. R. China

Institute for Biomedical Materials and Devices Faculty of Science University of Technology Sydney 15 Broadway Ultimo New South Wales 2007 Australia

UTS‐SUStech Joint Research Centre for Biomedical Materials & Devices Department of Biomedical Engineering Southern University of Science and Technology Shenzhen 518055 P. R. China

Institute of Molecular Sciences and Engineering Shandong University Qingdao 266237 P. R. China

Funding

National Natural Science Foundation of China · CAS-Croucher Funding Scheme for Joint Laboratories · Natural Science Foundation of Guangdong Province

References (78)

Show source-provided references
1. 10.1038/nrc.2016.2510.1038/nrc.2016.25 ↗
2. 10.1038/nature1703810.1038/nature17038 ↗
3. 10.1038/3502522010.1038/35025220 ↗
4. 10.1021/acsnano.9b0287510.1021/acsnano.9b02875 ↗
5. 10.1038/nature0132210.1038/nature01322 ↗
6. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
7. 10.1056/NEJMoa150059610.1056/NEJMoa1500596 ↗
8. 10.1021/acs.chemrev.7b0025810.1021/acs.chemrev.7b00258 ↗
9. 10.1021/ja404985w10.1021/ja404985w ↗
10. 10.1002/adma.20190582510.1002/adma.201905825 ↗
11. 10.1016/j.cell.2017.11.03510.1016/j.cell.2017.11.035 ↗
12. 10.1002/adma.20180832510.1002/adma.201808325 ↗
13. 10.1038/s41467-018-07197-810.1038/s41467-018-07197-8 ↗
14. 10.1002/adma.20190527110.1002/adma.201905271 ↗
15. 10.1002/smll.20190714610.1002/smll.201907146 ↗
16. 10.1016/j.biomaterials.2020.12009310.1016/j.biomaterials.2020.120093 ↗
17. 10.1016/j.biomaterials.2020.11997110.1016/j.biomaterials.2020.119971 ↗
18. 10.1002/adhm.20170115610.1002/adhm.201701156 ↗
19. 10.1021/acsnano.9b0574910.1021/acsnano.9b05749 ↗
20. 10.1002/adma.20200054210.1002/adma.202000542 ↗
21. 10.1038/s41551-019-0385-410.1038/s41551-019-0385-4 ↗
22. 10.1021/acs.accounts.9b0028310.1021/acs.accounts.9b00283 ↗
23. 10.1039/C9MH01824G10.1039/C9MH01824G ↗
24. 10.1021/ja805655b10.1021/ja805655b ↗
25. 10.1021/ja508641z10.1021/ja508641z ↗
26. 10.1021/ja409754v10.1021/ja409754v ↗
27. 10.1021/nn506687t10.1021/nn506687t ↗
28. 10.1002/adma.20150266910.1002/adma.201502669 ↗
29. 10.1016/j.biomaterials.2017.05.03710.1016/j.biomaterials.2017.05.037 ↗
30. 10.1021/acsnano.7b0739310.1021/acsnano.7b07393 ↗
31. 10.1038/s41565-019-0527-610.1038/s41565-019-0527-6 ↗
32. 10.1021/jacs.9b1292910.1021/jacs.9b12929 ↗
33. 10.1002/anie.20181008210.1002/anie.201810082 ↗
34. 10.1002/smll.20190347310.1002/smll.201903473 ↗
35. 10.1002/anie.20190988310.1002/anie.201909883 ↗
36. 10.1002/adma.20190658010.1002/adma.201906580 ↗
37. 10.1021/cg101283w10.1021/cg101283w ↗
38. 10.1158/0008-5472.CAN-16-348010.1158/0008-5472.CAN-16-3480 ↗
39. 10.1038/nrd242510.1038/nrd2425 ↗
40. 10.1073/pnas.130624111010.1073/pnas.1306241110 ↗
41. 10.1002/anie.20120770110.1002/anie.201207701 ↗
42. 10.1002/anie.20171252810.1002/anie.201712528 ↗
43. 10.1039/C6SC05646F10.1039/C6SC05646F ↗
44. 10.1002/anie.20190738810.1002/anie.201907388 ↗
45. 10.1016/j.chempr.2019.06.00310.1016/j.chempr.2019.06.003 ↗
46. 10.1016/j.chempr.2020.05.00810.1016/j.chempr.2020.05.008 ↗
47. 10.1021/jacs.7b1103610.1021/jacs.7b11036 ↗
48. 10.1007/s12274-017-1950-310.1007/s12274-017-1950-3 ↗
49. 10.1002/smll.20170427210.1002/smll.201704272 ↗
50. 10.1016/j.mattod.2013.11.00310.1016/j.mattod.2013.11.003 ↗
51. 10.1002/anie.20151059710.1002/anie.201510597 ↗
52. 10.1038/nbt134010.1038/nbt1340 ↗
53. 10.1021/acsnano.9b0857010.1021/acsnano.9b08570 ↗
54. 10.1039/C9SC06260B10.1039/C9SC06260B ↗
55. 10.1038/s41565-018-0319-410.1038/s41565-018-0319-4 ↗
56. 10.1002/adma.20190499710.1002/adma.201904997 ↗
57. 10.1021/acsnano.5b0677910.1021/acsnano.5b06779 ↗
58. 10.1002/anie.20191252410.1002/anie.201912524 ↗
59. 10.1177/030006051879961210.1177/0300060518799612 ↗
60. AbdelAziz R. J. · Antibody Ther. · 2020 · 3 · 8010.1093/abt/tbaa006 ↗
61. 10.1016/j.blre.2018.04.00510.1016/j.blre.2018.04.005 ↗
62. 10.1002/adma.20190499710.1002/adma.201904997 ↗
63. 10.1002/anie.20190972910.1002/anie.201909729 ↗
64. 10.1002/adfm.20190795410.1002/adfm.201907954 ↗
65. 10.1039/C9CC06040E10.1039/C9CC06040E ↗
66. 10.1021/acs.nanolett.9b0224210.1021/acs.nanolett.9b02242 ↗
67. 10.1002/med.2017410.1002/med.20174 ↗
68. 10.1038/s41467-019-12771-910.1038/s41467-019-12771-9 ↗
69. 10.1126/sciadv.aba159010.1126/sciadv.aba1590 ↗
70. 10.1038/s41551-020-0560-710.1038/s41551-020-0560-7 ↗
71. 10.1126/sciadv.aaz924010.1126/sciadv.aaz9240 ↗
72. 10.1016/j.biomaterials.2020.11975510.1016/j.biomaterials.2020.119755 ↗
73. 10.1126/science.aaa817210.1126/science.aaa8172 ↗
74. 10.1126/scitranslmed.aad711810.1126/scitranslmed.aad7118 ↗
75. 10.1002/adfm.20190124010.1002/adfm.201901240 ↗
76. 10.1021/acsnano.9b0832010.1021/acsnano.9b08320 ↗
77. 10.1016/j.biomaterials.2020.11992810.1016/j.biomaterials.2020.119928 ↗
78. 10.1038/nnano.2016.16810.1038/nnano.2016.168 ↗